6533b863fe1ef96bd12c77c4

RESEARCH PRODUCT

Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up

Alessandro MarrellaEmanuele AmodioClaudio CostantinoVitale FrancescoMaria Gabriella VersoPalmira Immordino

subject

HBsAgImmunologylcsh:MedicineBooster doseHepatitis b surface antigenmedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineNursingInterquartile rangeDrug Discoverypersistence of protectionMedicinePharmacology (medical)030212 general & internal medicineHCWs healthPharmacologyHepatitis B virusBooster (rocketry)biologybusiness.industrySettore MED/44 - Medicina Del Lavorolcsh:Rvaccine boostervirus diseasesdigestive system diseasesTiterInfectious Diseaseshepatitis B virus (HBV)biology.protein030211 gastroenterology & hepatologyAntibodybusinessanamnestic responseoccupational visit

description

Infection caused by hepatitis B virus (HBV) can be prevented through a safe and effective vaccine. This study analysed the kinetics of serum antibodies against hepatitis B surface antigen (HBsAg) (anti-HBs) titers in relation to previous vaccine boosters in Italian nursing students who were followed up for two years. Serum anti-HBs titers were evaluated at the first visit, after vaccine booster (if required) and at visit after two years. Overall, 483 students (mean age = 21.7 years

yearjournalcountryeditionlanguage
2020-08-21
10.3390/vaccines8030467http://hdl.handle.net/10447/430967